Xoma reported $8.42M in Current Liabilities for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agenus AGEN:US $ 159.72M 3.34M
Agios Pharmaceuticals AGIO:US $ 48.4M 2.6M
Ardelyx ARDX:US $ 48.7M 0.86M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Bluebird Bio BLUE:US $ 148.86M 5.97M
Celldex Therapeutics CLDX:US $ 29.95M 15.39M
Chimerix CMRX:US $ 23.27M 8.06M
Curis CRIS:US $ 12.15M 2.46M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Emergent Biosolutions EBS:US $ 276.7M 27.5M
Epizyme EPZM:US $ 34.95M 4.01M
Intercept Pharmaceuticals ICPT:US $ 151.43M 0.39M
Life Technologies LIFE:US $ 9.26M 2.99M
Macrogenics MGNX:US $ 50.88M 16.22M
Novartis NOVN:VX SF 27646M 2161M
Novartis NVS:US $ 27646M 2161M
Prothena PRTA:US 40.11M 3.61M
Regeneron Pharmaceuticals REGN:US $ 3033.9M 26.3M
Teva Pharmaceutical Industries TEVA:US $ 10996M 617M
Xoma XOMA:US $ 8.42M 534K
YTE INCY:US $ 926.67M 40.51M